Stocks · Healthcare · Medical - Healthcare Information Services
Claritev Corporation CTEV
$23.72 +11.31% Close, Oct 2, 2026 · NYSE · Market cap $404.4M
High risk
Next earnings report: Nov 6, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Operating margin widened to 4.9% from -37.8% a year earlier.
- The stock is 67% below its highest close of the past year.
- Net debt is 7.8× EBITDA, a high level of leverage.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Bottom 43%
- Revenue growth, 3-year CAGRBottom 17%
- Revenue growth accelerationTop 38%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalTop 31%
- Gross marginBottom 29%
- Operating marginTop 34%
- Accruals (lower is better)Top 39%
- Net debt / EBITDA (lower is better)Bottom 8%
- Interest coverTop 44%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 10%
- Free-cash-flow yieldTop 50%
- EBITDA / enterprise valueTop 6%
- Sales / enterprise valueBottom 47%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 25%
- 6-month returnTop 28%
- 1-year return vs S&P 500Bottom 10%
- Distance from 52-week highBottom 10%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersBottom 5%
- Consecutive EPS beatsBottom 49%
- Share of analysts rating BuyTop 38%
- Upside to consensus price targetTop 32%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 9%
- Maximum drawdown, 3 yearsBottom 30%
- Beta vs S&P 500 (lower is better)Bottom 8%
- Net debt / EBITDA (lower is better)Bottom 8%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 5.5% | 6.3% | ↑ |
| Gross margin | 74.4% | 44.3% | ↓ |
| Operating margin | -37.8% | 4.9% | ↑ |
| FCF margin | -5.9% | -1.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 6.3% | 5.5% | ↑ | Bottom 43% |
| Gross margin | 44.3% | 74.4% | ↓ | Bottom 29% |
| Operating margin | 4.9% | -37.8% | ↑ | Top 34% |
| Net margin | -28.5% | -70.9% | ↑ | — |
| Free-cash-flow margin | -1.8% | -5.9% | ↑ | — |
| Return on invested capital | 0.9% | — | Top 31% | |
| Revenue growth, 3-year CAGR | -3.7% | — | Bottom 17% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -8.7%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- 2.9%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -1.9 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- 7.80×
- Interest cover (operating income / interest)How many times operating profit covers interest.
- 0.1×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- 0.37%
- Shareholder yield
- 0.37%
- Share count change, 1 year
- +3.1%
- Share count change, 3-year CAGR
- +1.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 7, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 1
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- -100.0%
- Average 2-day reaction, last 8
- +3.2%
- Positive 20 days after report
- 4 of 7
Analysts
- Consensus price target
- $52.00
- Target vs current price
- +119.2%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 83%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 7, 2026 | +15.3% | +21.4% | +57.3% | +45.6% | — |
| May 7, 2026 | -15.7% | -8.5% | +4.2% | +4.2% | -8.2% |
| Feb 23, 2026 | -674.1% | -0.2% | -42.1% | -36.0% | -29.4% |
| Nov 7, 2025 | -35.6% | +11.8% | -28.7% | -45.2% | -59.3% |
| Aug 6, 2025 | -41.6% | +29.4% | +66.2% | +73.0% | +73.6% |
| May 8, 2025 | -99.1% | +1.6% | +26.5% | +80.9% | +85.2% |
| Feb 25, 2025 | +10.1% | -32.8% | -34.1% | -27.2% | -1.6% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 7, 2026 | -$3.49 | -$4.12 | +15.3% | $257.5M |
| May 7, 2026 | -$4.41 | -$3.81 | -15.7% | $244.7M |
| Feb 23, 2026 | -$4.88 | $0.85 | -674.1% | $246.6M |
| Nov 7, 2025 | -$4.23 | -$3.12 | -35.6% | $246.0M |
| Aug 6, 2025 | -$3.81 | -$2.69 | -41.6% | $241.6M |
| May 8, 2025 | -$4.38 | -$2.20 | -99.1% | $231.3M |
| Feb 25, 2025 | -$8.82 | -$9.81 | +10.1% | $232.1M |
| Nov 5, 2024 | -$24.25 | -$2.75 | -782.9% | $230.5M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / EBITDA | 8.5× | — | — | Top 6% |
| EV / Sales | 5.04× | — | — | Bottom 47% |
| Free-cash-flow yield | -4.43% | — | — | Top 50% |
| Earnings yield | -71.71% | — | — | Bottom 10% |
P/E over the past five years
Range 2.9× – 4.6× since Dec 31, 2021. Each point: price on the filing date divided by trailing-twelve-month EPS known then.
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -1.3%
- 200-day average slope (20 days)
- -4.4%
- Distance from 50-day average
- -24.9%
- Distance from 200-day average
- -12.2%
- RSI (14)
- 33.2
- Relative volume
- 1.49×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 97.3%
- Volatility vs own 5-year history
- 41th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.26
- Correlation with S&P 500
- 0.27
- Current drawdown from 1-year high
- -66.8%
- Maximum drawdown, 3 years
- -81.4%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Aug 26, 2025 | Feb 27, 2026 | -81.4% | 127 days | Not yet recovered |
| Feb 24, 2025 | Mar 10, 2025 | -40.6% | 10 days | 56 days (May 29, 2025) |
| Jul 9, 2025 | Aug 1, 2025 | -22.9% | 17 days | 3 days (Aug 6, 2025) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $404.4M
- EPS, diluted (TTM)
- -$17.01
- Revenue (TTM)
- $994.7M
- 52-week range
- $11.50 – $73.68
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $1.12B | $1.08B | $961.5M | $930.6M | $965.4M |
| Gross profit | $942.3M | $875.6M | $726.1M | $691.2M | $266.6M |
| Operating income | $386.1M | -$362.7M | $162.0M | -$1.39B | $45.1M |
| Net income | $102.1M | -$572.9M | -$91.7M | -$1.65B | -$284.3M |
| EPS (diluted) | $6.40 | -$35.87 | -$5.69 | -$101.92 | -$17.30 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $230.5M | $232.1M | $231.3M | $241.6M | $246.0M | $246.6M | $244.7M | $257.5M |
| Net income | -$391.4M | -$138.0M | -$71.3M | -$62.6M | -$69.8M | -$80.6M | -$73.6M | -$59.2M |
| EPS (diluted) | -$24.25 | -$8.49 | -$4.38 | -$3.81 | -$4.23 | -$4.88 | -$4.41 | -$3.49 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | $404.7M | $372.4M | $171.7M | $107.6M | $117.3M |
| Capital expenditure | -$84.6M | -$89.7M | -$108.9M | -$118.1M | -$129.6M |
| Free cash flow | $320.1M | $282.6M | $62.9M | -$10.5M | -$12.3M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | -$100.0M | $0 | -$14.7M | -$10.4M | $1.7M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $14.4M
- Total assets
- $4.76B
- Total liabilities
- $5.05B
- Total debt
- $4.62B
- Net debt
- $4.61B
- Shareholders’ equity
- -$294.6M
As of Jun 30, 2026 (filed Aug 7, 2026).
Short interest
- Shares sold short
- 941,196
- Days to cover
- 8.55
- Change vs previous report
- +2.5%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Sep 23, 2024
- 1-for-40
- Jul 13, 2015
- 8-for-1